Annual SGA
$8.08 M
+$2.73 M+50.85%
December 1, 2023
Summary
- As of February 7, 2025, RVPH annual SGA is $8.08 million, with the most recent change of +$2.73 million (+50.85%) on December 1, 2023.
- During the last 3 years, RVPH annual SGA has risen by +$5.94 million (+277.84%).
- RVPH annual SGA is now at all-time high.
Performance
RVPH SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.60 M
-$941.10 K-36.97%
September 1, 2024
Summary
- As of February 7, 2025, RVPH quarterly SGA is $1.60 million, with the most recent change of -$941.10 thousand (-36.97%) on September 1, 2024.
- Over the past year, RVPH quarterly SGA has dropped by -$387.60 thousand (-19.46%).
- RVPH quarterly SGA is now -47.90% below its all-time high of $3.08 million, reached on June 30, 2023.
Performance
RVPH Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$583.80 M
-$37.31 M-6.83%
September 1, 2024
Summary
- As of February 7, 2025, RVPH TTM SGA is -$583.80 million, with the most recent change of -$37.31 million (-6.83%) on September 1, 2024.
- Over the past year, RVPH TTM SGA has dropped by -$591.85 million (-7353.84%).
- RVPH TTM SGA is now -339520.64% below its all-time high of $172.00 thousand.
Performance
RVPH TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
RVPH Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +50.9% | -19.5% | -7353.8% |
| 3 y3 years | +277.8% | -47.9% | -8082.7% |
| 5 y5 years | +4363.7% | -47.9% | -8082.7% |
RVPH Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +53.9% | -47.9% | +59.6% | -133.4% | at low |
| 5 y | 5-year | at high | +4363.7% | -47.9% | +362.3% | <-9999.0% | at low |
| alltime | all time | at high | +4363.7% | -47.9% | +362.3% | <-9999.0% | at low |
Reviva Pharmaceuticals Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.60 M(-37.0%) | $7.80 M(-4.7%) |
| Jun 2024 | - | $2.55 M(+19.0%) | $8.19 M(-6.1%) |
| Mar 2024 | - | $2.14 M(+41.4%) | $8.72 M(+7.9%) |
| Dec 2023 | $8.08 M(+50.9%) | $1.51 M(-24.1%) | $8.08 M(+0.4%) |
| Sep 2023 | - | $1.99 M(-35.3%) | $8.05 M(+10.0%) |
| Jun 2023 | - | $3.08 M(+105.2%) | $7.31 M(+39.6%) |
| Mar 2023 | - | $1.50 M(+1.6%) | $5.24 M(-2.2%) |
| Dec 2022 | $5.36 M | $1.48 M(+17.5%) | $5.36 M(+3.4%) |
| Sep 2022 | - | $1.26 M(+25.1%) | $5.18 M(+4.1%) |
| Jun 2022 | - | $1.01 M(-38.0%) | $4.98 M(-7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.62 M(+24.4%) | $5.39 M(+2.6%) |
| Dec 2021 | $5.25 M(+145.5%) | $1.30 M(+23.6%) | $5.25 M(+17.3%) |
| Sep 2021 | - | $1.05 M(-25.6%) | $4.48 M(+13.8%) |
| Jun 2021 | - | $1.42 M(-4.4%) | $3.93 M(+20.7%) |
| Mar 2021 | - | $1.48 M(+181.2%) | $3.26 M(+53.3%) |
| Dec 2020 | $2.14 M(+1081.4%) | $526.70 K(+3.0%) | $2.13 M(+32.9%) |
| Sep 2020 | - | $511.30 K(-31.0%) | $1.60 M(+47.0%) |
| Jun 2020 | - | $740.90 K(+113.5%) | $1.09 M(+213.5%) |
| Mar 2020 | - | $347.00 K | $347.00 K |
| Dec 2019 | $181.10 K | - | - |
FAQ
- What is Reviva Pharmaceuticals Holdings annual SGA?
- What is the all time high annual SGA for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings annual SGA year-on-year change?
- What is Reviva Pharmaceuticals Holdings quarterly SGA?
- What is the all time high quarterly SGA for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings quarterly SGA year-on-year change?
- What is Reviva Pharmaceuticals Holdings TTM SGA?
- What is the all time high TTM SGA for Reviva Pharmaceuticals Holdings?
- What is Reviva Pharmaceuticals Holdings TTM SGA year-on-year change?
What is Reviva Pharmaceuticals Holdings annual SGA?
The current annual SGA of RVPH is $8.08 M
What is the all time high annual SGA for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high annual SGA is $8.08 M
What is Reviva Pharmaceuticals Holdings annual SGA year-on-year change?
Over the past year, RVPH annual SGA has changed by +$2.73 M (+50.85%)
What is Reviva Pharmaceuticals Holdings quarterly SGA?
The current quarterly SGA of RVPH is $1.60 M
What is the all time high quarterly SGA for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high quarterly SGA is $3.08 M
What is Reviva Pharmaceuticals Holdings quarterly SGA year-on-year change?
Over the past year, RVPH quarterly SGA has changed by -$387.60 K (-19.46%)
What is Reviva Pharmaceuticals Holdings TTM SGA?
The current TTM SGA of RVPH is -$583.80 M
What is the all time high TTM SGA for Reviva Pharmaceuticals Holdings?
Reviva Pharmaceuticals Holdings all-time high TTM SGA is $172.00 K
What is Reviva Pharmaceuticals Holdings TTM SGA year-on-year change?
Over the past year, RVPH TTM SGA has changed by -$591.85 M (-7353.84%)